These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7214844)

  • 21. [Proceedings: Changes of serum glycoproteins in arterial vascular diseases].
    Haerle M; Müller H; Schlosser V; Marx T; Kluthe R
    MMW Munch Med Wochenschr; 1974 May; 116(22):1112. PubMed ID: 4211578
    [No Abstract]   [Full Text] [Related]  

  • 22. Distribution of blood viscosity values and biochemical correlates in healthy adults.
    Kharb S; Singh GP
    J Assoc Physicians India; 1999 May; 47(5):505-6. PubMed ID: 10778561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Need for treatment of elevated plasma fibrinogen levels in cerebrovascular disease.
    Clark WM; Coull BM; Beamer NB
    Heart Dis Stroke; 1993; 2(6):503-6. PubMed ID: 8137058
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide].
    Messa G; La Placa G; Puccetti L; Di Perri T
    Minerva Cardioangiol; 1997 Apr; 45(4):147-53. PubMed ID: 9213829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The behavior of some metabolic and instrumental parameters in diabetics with arteriopathy of the lower extremities treated with increasing doses of glucuronyl-glycosaminoglycano-sulfate].
    Marigo S
    Clin Ter; 1980 Jun; 93(5):503-18. PubMed ID: 7428314
    [No Abstract]   [Full Text] [Related]  

  • 26. Plasma viscosity in 615 subjects. Effect of fibrinogen, globulin, and cholesterol in normals, peripheral vascular disease retinopathy, and melanoma.
    Dintenfass L; Kammer S
    Biorheology; 1977; 14(5-6):247-51. PubMed ID: 610778
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in blood serum protein fractions in obliterating vascular diseases of the extremities following nivaline-electrophoresis therapy].
    Todorov N
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):512-6. PubMed ID: 5515367
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of erythrocyte morphology as deformability index in patients suffering from vascular diseases, with or without diabetes mellitus: correlation with blood viscosity and intra-erythrocytic calcium.
    Turchetti V; Leoncini F; De Matteis C; Trabalzini L; Guerrini M; Forconi S
    Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):141-9. PubMed ID: 9699035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of bezafibrate in the diet of hypertensive patients with dyslipidemia and hyperfibrinogenemia].
    Vázquez-Chávez C; Salinas-Orozco S; Gómez-Díaz RA; Rosso-Juárez MM; Moreno-Vázquez K; Nissen-Torres T; Argüero-Sánchez R
    Rev Invest Clin; 1998; 50(6):491-6. PubMed ID: 10070221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulodexide: a renewed interest in this glycosaminoglycan.
    Lauver DA; Lucchesi BR
    Cardiovasc Drug Rev; 2006; 24(3-4):214-26. PubMed ID: 17214598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinico-experimental contribution on the role of mucopolysaccharides in homeostasis of the microcirculation].
    Pasta V; Criscuolo A
    Ann Ital Chir; 1982; 54(6):565-73. PubMed ID: 6224450
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemorheology and hemostasis in vascular disease. A pathophysiological review.
    Angelkort B; Amann B; Lawall H
    Clin Hemorheol Microcirc; 2002; 26(3):145-54. PubMed ID: 12082246
    [No Abstract]   [Full Text] [Related]  

  • 33. [Rheology and coronary heart disease].
    Leschke M
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S270-3. PubMed ID: 19085805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Coping with stress and blood viscosity in stroke prevention patients].
    Anders I; Esterbauer E; Ladurner G; Wranek U
    Wien Klin Wochenschr; 2001 May; 113(10):378-83. PubMed ID: 11432127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemorheological and antioxidant effects of Ascovertin in patients with sclerosis of cerebral arteries.
    Plotnikov MB; Plotnikov DM; Aliev OI; Maslov MY; Vasiliev AS; Alifirova VM; Tyukavkina NA
    Clin Hemorheol Microcirc; 2004; 30(3-4):449-52. PubMed ID: 15258384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clinofibrate on plasma fibrinogen level in high fructose diet-induced hyperlipidemic rats.
    Okazaki M; Zhang H; Ichino K; Amamiya M; Nakayama S; Oguchi K
    In Vivo; 1994; 8(6):1057-61. PubMed ID: 7772737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure.
    Reinhart WH; Oswald J; Walter R; Kuhn M
    Clin Hemorheol Microcirc; 2002; 27(3-4):201-7. PubMed ID: 12454377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome.
    Jastrzebska M; Torbus-Lisiecka B; Pieczul-Mróz J; Chelstowski K; Kopciewicz J; Naruszewicz M
    Int J Clin Pharmacol Res; 1999; 19(1):19-25. PubMed ID: 10450539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid levels and vascular disease.
    Daskalopoulou SS; Athyros VG; Elisaf M; Mikhailidis DP
    Curr Med Res Opin; 2004 Jun; 20(6):951-4. PubMed ID: 15200754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
    Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
    Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.